Xilio Therapeutics, Inc.

XLO Nasdaq CIK: 0001840233

Company Information

Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 828 WINTER STREET, WALTHAM, MA, 02451
Mailing Address 828 WINTER STREET, WALTHAM, MA, 02451
Phone 617-833-1027
Fiscal Year End 1231
EIN 851623397

Financial Overview

FY2024

$55.29M
Cash & Equivalents

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment February 13, 2026 View on SEC
424B5 Prospectus supplement February 12, 2026 View on SEC
8-K Current report of material events February 12, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 12, 2026 View on SEC
424B5 Prospectus supplement February 11, 2026 View on SEC
DEF 14A Definitive proxy statement January 26, 2026 View on SEC
8-K Current report of material events January 8, 2026 View on SEC
4 Insider stock transaction report January 5, 2026 View on SEC
4 Insider stock transaction report January 5, 2026 View on SEC
8-K Current report of material events January 5, 2026 View on SEC

Insider Trading

SELL 2 insiders 2 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2834)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.